Processes like horizon scanning and the HTA review will quickly descend into an obscurantist discussion on technical inputs without clear direction from health minister Mark Butler on what specific outcomes the government wants.
This process needs clear direction from the Government or it will go nowhere
December 7, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 1 August
August 1, 2025 - - Podcast -
Trump administration takes another step in 'Most Favored Nation' push
August 1, 2025 - - Latest News -
Novartis backs the launch of a new cardiovascular disease program
August 1, 2025 - - Latest News -
Study reveals growing benefit of Lilly therapy for early symptomatic Alzheimer’s disease
August 1, 2025 - - Latest News -
New pharmacy-focused partnership marks the launch of two first-to-market biosimilars
August 1, 2025 - - Latest News -
Arrotex expands haematology-oncology portfolio through Antengene partnership
August 1, 2025 - - Latest News -
AbbVie therapy now available on the PBS for treatment of advanced Parkinson’s
August 1, 2025 - - Latest News